21 CFR Part 201 - LABELING
- Subpart A - General Labeling Provisions (§§ 201.1 - 201.26)
- Subpart B - Labeling Requirements for Prescription Drugs and/or Insulin (§§ 201.50 - 201.58)
- Subpart C - Labeling Requirements for Over-the-Counter Drugs (§§ 201.60 - 201.80)
- Subpart D - Exemptions From Adequate Directions for Use (§§ 201.100 - 201.129)
- Subpart E - Other Exemptions (§§ 201.150 - 201.161)
- Subpart F - Labeling Claims for Drugs in Drug Efficacy Study (§ 201.200)
- Subpart G - Specific Labeling Requirements for Specific Drug Products (§§ 201.300 - 201.328)
- Appendix A to Part 201 - Examples of Graphic Enhancements Used by FDA
{'United States Code': [{'Title': '42', 'Section': '216', 'headtext': ' Regulations', 'cleanpath': '/uscode/text/42/216'}, {'Title': '42', 'Section': '241', 'headtext': ' Research and investigations generally', 'cleanpath': '/uscode/text/42/241'}, {'Title': '42', 'Section': '262', 'headtext': ' Regulation of biological products', 'cleanpath': '/uscode/text/42/262'}, {'Title': '42', 'Section': '264', 'headtext': ' Regulations to control communicable diseases', 'cleanpath': '/uscode/text/42/264'}, {'Title': '21', 'Section': '321', 'headtext': ' Definitions; generally', 'cleanpath': '/uscode/text/21/321'}, {'Title': '21', 'Section': '331', 'headtext': ' Prohibited acts', 'cleanpath': '/uscode/text/21/331'}, {'Title': '21', 'Section': '351', 'headtext': ' Adulterated drugs and devices', 'cleanpath': '/uscode/text/21/351'}, {'Title': '21', 'Section': '352', 'headtext': ' Misbranded drugs and devices', 'cleanpath': '/uscode/text/21/352'}, {'Title': '21', 'Section': '353', 'headtext': ' Exemptions and consideration for certain drugs, devices, and biological products', 'cleanpath': '/uscode/text/21/353'}, {'Title': '21', 'Section': '355', 'headtext': ' New drugs', 'cleanpath': '/uscode/text/21/355'}, {'Title': '21', 'Section': '358', 'headtext': ' Authority to designate official names', 'cleanpath': '/uscode/text/21/358'}, {'Title': '21', 'Section': '360', 'headtext': ' Registration of producers of drugs or devices', 'cleanpath': '/uscode/text/21/360'}, {'Title': '21', 'Section': '360b', 'headtext': ' New animal drugs', 'cleanpath': '/uscode/text/21/360b'}, {'Title': '21', 'Section': '360ss', 'headtext': ' State standards', 'cleanpath': '/uscode/text/21/360ss'}, {'Title': '21', 'Section': '360gg', 'headtext': '', 'cleanpath': '/uscode/text/21/360gg'}, {'Title': '21', 'Section': '371', 'headtext': ' Regulations and hearings', 'cleanpath': '/uscode/text/21/371'}, {'Title': '21', 'Section': '374', 'headtext': ' Inspection', 'cleanpath': '/uscode/text/21/374'}, {'Title': '21', 'Section': '379e', 'headtext': ' Listing and certification of color additives for foods, drugs, devices, and cosmetics', 'cleanpath': '/uscode/text/21/379e'}], 'Statutes at Large': [], 'Public Laws': [], 'Presidential Documents': []}